A Phase 2 Bridging Study to Assess the New Formulation of ETVAX

NCT05178134 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
280
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Scandinavian Biopharma AB

Collaborators